117 related articles for article (PubMed ID: 28951255)
1. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
[TBL] [Abstract][Full Text] [Related]
2. The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats.
Janic M; Lunder M; Cerne D; Marc J; Jerin A; Skitek M; Drevensek G; Sabovic M
J Cardiovasc Pharmacol; 2016 Jul; 68(1):74-80. PubMed ID: 27010807
[TBL] [Abstract][Full Text] [Related]
3. Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.
Lunder M; Ziberna L; Janić M; Jerin A; Skitek M; Sabovič M; Drevenšek G
Heart Vessels; 2013 Mar; 28(2):246-54. PubMed ID: 22610592
[TBL] [Abstract][Full Text] [Related]
4. Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas.
Lunder M; Drevenšek G; Černe D; Marc J; Janić M; Šabovič M
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):177-83. PubMed ID: 23091284
[TBL] [Abstract][Full Text] [Related]
5. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
6. Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property.
Matsuki A; Igawa A; Nozawa T; Nakadate T; Igarashi N; Nonomura M; Inoue H
Circ J; 2006 Dec; 70(12):1643-9. PubMed ID: 17127814
[TBL] [Abstract][Full Text] [Related]
7. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
8. Reduction of myocardial infarct size by fluvastatin.
Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790
[TBL] [Abstract][Full Text] [Related]
9. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
10. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
11. Preservation of endothelium-dependent and Nomega-nitro-L-arginine methyl ester- and indomethacin-resistant arterial relaxation in high-cholesterol-diet fed rabbits by treatment with fluvastatin, an HMG-CoA reductase inhibitor.
Mitani H; Kimura M
J Cardiovasc Pharmacol; 2003 Jul; 42(1):55-62. PubMed ID: 12827027
[TBL] [Abstract][Full Text] [Related]
12. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
13. Short term fluvastatin treatment lowers serum asymmetric dimethylarginine levels in patients with metabolic syndrome.
Oguz A; Uzunlulu M
Int Heart J; 2008 May; 49(3):303-11. PubMed ID: 18612188
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Suematsu N; Kinugawa S; Ide T; Wen J; Takeshita A
Circulation; 2002 Feb; 105(7):868-73. PubMed ID: 11854129
[TBL] [Abstract][Full Text] [Related]
16. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
[TBL] [Abstract][Full Text] [Related]
17. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
[TBL] [Abstract][Full Text] [Related]
18. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
19. Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide.
Skogastierna C; Luksha L; Kublickiene K; Eliasson E; Rane A; Ekström L
Heart Vessels; 2011 Nov; 26(6):628-36. PubMed ID: 21213109
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
